Your browser doesn't support javascript.
loading
Structural dynamics reveal subtype-specific activation and inhibition of influenza virus hemagglutinin.
Garcia, Natalie K; Kephart, Sally M; Benhaim, Mark A; Matsui, Tsutomu; Mileant, Alexander; Guttman, Miklos; Lee, Kelly K.
Affiliation
  • Garcia NK; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
  • Kephart SM; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
  • Benhaim MA; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
  • Matsui T; Stanford Synchrotron Radiation Laboratory, SLAC, Menlo Park, California, USA.
  • Mileant A; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
  • Guttman M; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
  • Lee KK; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, USA. Electronic address: kklee@uw.edu.
J Biol Chem ; 299(6): 104765, 2023 06.
Article in En | MEDLINE | ID: mdl-37121546
ABSTRACT
Influenza hemagglutinin (HA) is a prototypical class 1 viral entry glycoprotein, responsible for mediating receptor binding and membrane fusion. Structures of its prefusion and postfusion forms, embodying the beginning and endpoints of the fusion pathway, have been extensively characterized. Studies probing HA dynamics during fusion have begun to identify intermediate states along the pathway, enhancing our understanding of how HA becomes activated and traverses its conformational pathway to complete fusion. HA is also the most variable, rapidly evolving part of influenza virus, and it is not known whether mechanisms of its activation and fusion are conserved across divergent viral subtypes. Here, we apply hydrogen-deuterium exchange mass spectrometry to compare fusion activation in two subtypes of HA, H1 and H3. Our data reveal subtype-specific behavior in the regions of HA that undergo structural rearrangement during fusion, including the fusion peptide and HA1/HA2 interface. In the presence of an antibody that inhibits the conformational change (FI6v3), we observe that acid-induced dynamic changes near the epitope are dampened, but the degree of protection at the fusion peptide is different for the two subtypes investigated. These results thus provide new insights into variation in the mechanisms of influenza HA's dynamic activation and its inhibition.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Hemagglutinin Glycoproteins, Influenza Virus Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Hemagglutinin Glycoproteins, Influenza Virus Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Document type: Article